STOCK TITAN

Sema4 to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced that members of the Sema4 management team will participate in fireside chats at two upcoming virtual investor conferences. Eric Schadt, PhD, Founder and Chief Executive Officer, and Isaac Ro, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 and the Goldman Sachs Annual Global Healthcare Conference on Tuesday, June 8, 2021.

Event: Jefferies Virtual Healthcare Conference
Date: Friday, June 4, 2021
Time: 11:00 a.m. ET / 8:00 a.m. PT

Event: Goldman Sachs Annual Global Healthcare Conference
Date: Tuesday, June 8, 2021
Time: 1:20 p.m. ET / 10:20 a.m. PT

Following each conference, a Form 8-K with a copy of the transcript will be filed with the U.S. Securities and Exchange Commission (SEC). A link to the SEC filing will be available on the Company’s website at https://sema4.com/our-story/investors/.

About Sema4

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all. For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

CM Life Sciences Inc

NASDAQ:CMLF

CMLF Rankings

CMLF Latest News

CMLF Stock Data

Link
Finance, Financial Conglomerates

About CMLF

CM Life Sciences was founded to take advantage of a dynamic life science sector buoyed by innovation yet fragmented, where many companies are under-resourced and under-scaled. Significant and under-appreciated opportunities for consolidation are ready for engagement by a team versed in the trends and themes, and who can bring together the strongest of the new companies and management teams to capitalize on near- and far-term opportunities.